Chimeric antigen receptor (CAR)-T cell therapy is the next revolutionary advance in cancer
therapy. By using ex vivo engineered T cells to specifically target antigens, a targeted …

Abstract Treatment strategies to combat cardiogenic shock (CS) have remained stagnant
over the past decade. Mortality rates among patients who suffer CS after acute myocardial …

Background The appropriate use of pulmonary artery catheters (PACs) in critically ill cardiac
patients remains debated. Objectives The authors aimed to characterize the current use of …

Background The benefits of standardized care for cardiogenic shock (CS) across regional
care networks are poorly understood. Objectives The authors compared the management …

Purpose To investigate the impact of pulmonary artery catheter (PAC) monitoring on survival
of cardiogenic shock (CS), in the light of the controversies in available evidence. Materials …

The accurate assessment of hemodynamics is paramount to provide timely and efficacious
care for patients presenting in cardiogenic shock. Recently, the regular use of the pulmonary …

Cardiogenic shock is an extreme manifestation of acute decompensated heart failure.
Cardiogenic shock is often caused by—and has traditionally been studied in the setting of …

Septic shock management in the cardiac intensive care unit (CICU) is challenging due to the
complex interaction of pathophysiology between vasodilatory and cardiogenic shock …

Pulmonary artery catheterization is a diagnostic procedure in which a catheter is inserted
through a central vein and advanced toward the pulmonary artery to measure right atrial …

The role of continuous hemodynamic assessment with pulmonary artery (PA) catheter
placement in cardiogenic shock (CS) remains debated. We aimed to assess the association …